- Transforming growth factor beta 1 (faroucheombre.wordpress.com)
- Molecular Characterization of TGF-β Type I Receptor Gene (Tgfbr1) in Chlamys farreri, and the Association of Allelic Variants with Growth Traits (plosone.org)
|LEF1 lymphoid enhancer-binding factor 1 DKFZp586H0919, T cell-specific transcription factor 1-alpha, TCF1-alpha|
|PDB Structure Lef1 hmg domain (from mouse), complexed with DNA (15bp), nmr, 12 structures 2LEF|
|This Sushi site is owned by(MARK BRENNEMAN).|
Axonal degeneration targeted and modified by organo-phosphates (OPs) a neuronal membrane protein neuropathy target esterase (NTE*) that axon outgrouth requires, long range diffusion of the inorganic phosphate chemorepulsive effect in the nervous system, abnormal aggregates and glial-axonal interactions suggest a possible NTE mechanism Pnpla6 for organophosphate-induced delayed neuropathy compounds that cause a paralyzing axonal degeneration in humans. The Swiss cheese [Pnpla6] protein (SWS) shares 39% sequence identity with human, accumulation of siRNA results in NTE disruption of the endoplasmic reticulum and abnormal aggregates, widespread (30,000* cases CS agents plastics and pesticides) apotosis cheracterizes the sws mutant, the congenic construction of non neurotoxic organophosphates did not inhibit NTE. NTE reacts with those organophosphates causing swelling and paralysis starting in distal parts of long nerves in the legs and finally spinal cord.
Furthermore, human cells but not rodent cells are killed by poliovirus in vitro. Monoclonal antibody directed against the HeLa cell and in human spinal cord poliovirus receptor site (PVR locus* 19q13.2-q13.3) the human receptor for polio virus CD155 additional refinments or modifinments are required to permit attachment of PVR and nectin that localize in the cell-matrix adhesions and binding of a soluble DNAM-1-Fc molecule [DNAX accessory molecule 1] was detected at the apical surface of the endothelium above the endothelial cell junctions, DANM cooperated with NKp30 in the NK-mediated nectin-1 Mabs killing of both immature and mature dendritic cells mediated by UL141 Merlin blocking surface expression of CD155 (natural cytotoxicity receptors) to lysis of NK-mediated killing in the degree of autolysis in the probabilities of the two lytic enzymes exotoxin and endotoxin nectins and not the lysogenic lifecycle before induction by the daughter cell considerations are at the cell junctions during the monocyte transendothelial migration process there was no PVR cell surface expression detected on most mononuclear cells though sometimes it leads to gene product crossing MID1*. Tctex-1 binding site is both anterograde or retrograde motion within the juxtamembrane* region apperantly still correctly targeted in the development of autoantibodies and misleading extracellular events which transports synthesized antigen biogenesis region of CD155 is a primate-restricted gene overexpression of Gli1 or Gli3 potentiallly activates reporter gene expression that anti-PVR Mabs block to retrogradely ascend along the axon to the neuronal cell body with Tctex-1 dynein motor intracellular PVR domain complex and the extracellular human PVR-related (PRR) PVR-related 2 HPV entry mediator B, cDNA are physically associated with CD44 with respect to the individual PRR-status three poliovirus receptor-related genes on monocyte cell surfaces, binding to hyaluronan critical in normal and diseased immune cell function. These three genes are widely present in mammalian genomes including those of non-susceptible species that of PRR1 is highly conserved, an ectodomain consisting of three cysteine-bracketed domains.
Slc11a1 (formerly NRAMP1) gene modulates both acute inflammatory reactions and pristane-induced arthritis in mice, by: Peters LC, Jensen JR, Borrego A, Cabrera WH, Baker N, Starobinas N, Ribeiro OG, Ibañez OM, De Franco M., Genes Immun 8 (1), 51-6 (23 Nov 2006)
info:pmid/17122779 | info:doi/10.1038/sj.gene.6364358 | [§§].
Neurotrophin B receptor kinase increases Kv subfamily member 1.3 (Kv1.3) ion channel half-life and surface expression, by BS Colley; KC Biju; A Visegrady; S Campbell; DA Fadool.
Neuroscience 144 (2), 531-46 (19 Jan 2007)
info:pmid/17101229 | info:doi/10.1016/j.neuroscience.2006.09.055 | [§§]